MicroRNA in inflammatory bowel disease: Translational research and clinical implication

World J Gastroenterol. 2015 Nov 21;21(43):12274-82. doi: 10.3748/wjg.v21.i43.12274.

Abstract

Idiopathic inflammatory bowel disease (IBD) predominantly includes ulcerative colitis and Crohn's disease. The pathogenesis of IBD is complex and not completely understood. MicroRNAs belong to a class of noncoding small RNAs that post-transcriptionally regulate gene expression. Unique microRNA expression profiles have been explored in IBD. In this review, we focus on the unique microRNA expression pattern in both tissue and peripheral blood from IBD patients and emphasize the potential diagnostic and therapeutic applications. The discovery of microRNAs has contributed to our understanding of IBD pathogenesis and might lead to clinical advance in new therapeutics.

Keywords: Crohn’s disease; Gene expression; Inflammatory bowel disease; MicroRNA; Pathogenesis; Ulcerative colitis.

Publication types

  • Review

MeSH terms

  • Animals
  • Gene Expression Profiling
  • Gene Expression Regulation
  • Genetic Markers
  • Genetic Predisposition to Disease
  • Humans
  • Inflammatory Bowel Diseases / diagnosis
  • Inflammatory Bowel Diseases / genetics*
  • Inflammatory Bowel Diseases / therapy
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Molecular Diagnostic Techniques
  • Phenotype
  • Predictive Value of Tests
  • Prognosis
  • Translational Research, Biomedical

Substances

  • Genetic Markers
  • MicroRNAs